SignatureFD’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Sell
16,403
-58
-0.4% -$5.56K 0.02% 315
2025
Q4
$1.58M Buy
16,461
+591
+4% +$57.4K 0.02% 272
2025
Q3
$1.51M Buy
15,870
+886
+6% +$81.4K 0.02% 278
2025
Q2
$1.31M Buy
14,984
+659
+5% +$55.9K 0.02% 297
2025
Q1
$1.29M Buy
14,325
+1,797
+14% +$161K 0.02% 273
2024
Q4
$1M Sell
12,528
-804
-6% -$69.6K 0.02% 336
2024
Q3
$1.2M Buy
13,332
+551
+4% +$46.4K 0.02% 288
2024
Q2
$1.01M Buy
12,781
+325
+3% +$26.6K 0.02% 302
2024
Q1
$1.09M Sell
12,456
-309
-2% -$26.4K 0.02% 286
2023
Q4
$1.05M Sell
12,765
-2,835
-18% -$216K 0.02% 273
2023
Q3
$1.22M Buy
15,600
+1,061
+7% +$88.8K 0.03% 218
2023
Q2
$1.28M Buy
14,539
+304
+2% +$26.2K 0.03% 206
2023
Q1
$1.15M Buy
14,235
+2,629
+23% +$214K 0.03% 216
2022
Q4
$902K Sell
11,606
-671
-5% -$54.4K 0.03% 247
2022
Q3
$991K Sell
12,277
-84
-0.7% -$7.55K 0.03% 197
2022
Q2
$1.11M Sell
12,361
-3,395
-22% -$344K 0.04% 172
2022
Q1
$1.75M Buy
15,756
+2,509
+19% +$265K 0.05% 131
2021
Q4
$1.37M Buy
13,247
+1,793
+16% +$208K 0.04% 155
2021
Q3
$1.44M Sell
11,454
-526
-4% -$68.1K 0.05% 134
2021
Q2
$1.49M Buy
11,980
+2,351
+24% +$295K 0.06% 124
2021
Q1
$1.14M Buy
9,629
+1,001
+12% +$117K 0.05% 145
2020
Q4
$1.01M Buy
8,628
+625
+8% +$68.8K 0.05% 133
2020
Q3
$832K Buy
8,003
+360
+5% +$36.2K 0.04% 152
2020
Q2
$701K Buy
7,643
+157
+2% +$15.1K 0.04% 160
2020
Q1
$675K Sell
7,486
-3,286
-31% -$350K 0.06% 146
2019
Q4
$1.22M Buy
10,772
+1,001
+10% +$110K 0.09% 98
2019
Q3
$1.06M Buy
9,771
+1,052
+12% +$110K 0.09% 89
2019
Q2
$849K Buy
8,719
+642
+8% +$58.6K 0.07% 104
2019
Q1
$736K Sell
8,077
-2,298
-22% -$206K 0.06% 127
2018
Q4
$944K Buy
10,375
+1,345
+15% +$126K 0.09% 89
2018
Q3
$888K Buy
9,030
+1,394
+18% +$129K 0.09% 112
2018
Q2
$654K Buy
7,636
+957
+14% +$79.9K 0.07% 133
2018
Q1
$536K Buy
6,679
+1,017
+18% +$83.9K 0.06% 134
2017
Q4
$457K Sell
5,662
-101
-2% -$8.09K 0.06% 161
2017
Q3
$448K Buy
5,763
+371
+7% +$30.8K 0.06% 142
2017
Q2
$479K Sell
5,392
-1,629
-23% -$137K 0.07% 118
2017
Q1
$566K Buy
7,021
+3,302
+89% +$258K 0.08% 103
2016
Q4
$265K Sell
3,719
-855
-19% -$67.2K 0.04% 172
2016
Q3
$395K Buy
4,574
+87
+2% +$7.58K 0.06% 120
2016
Q2
$389K Sell
4,487
-68
-1% -$5.5K 0.06% 101
2016
Q1
$342K Buy
4,555
+910
+25% +$68.5K 0.06% 103
2015
Q4
$280K Buy
3,645
+335
+10% +$25.2K 0.05% 114
2015
Q3
$222K Sell
3,310
-118
-3% -$8.69K 0.05% 125
2015
Q2
$254K Buy
3,428
+53
+2% +$4.05K 0.06% 125
2015
Q1
$263K Buy
+3,375
New +$256K 0.06% 111
2014
Q4
Sell
-422
Closed -$26K 923
2014
Q3
$26K Hold
422
0.01% 328
2014
Q2
$27K Sell
422
-98
-19% -$5.95K 0.01% 323
2014
Q1
$32K Sell
520
-48
-8% -$2.8K 0.01% 258
2013
Q4
$33K Buy
568
+200
+54% +$11.3K 0.01% 274
2013
Q3
$20K Buy
368
+357
+3,245% +$19.2K 0.01% 325
2013
Q2
$1K Buy
+11
New +$544 ﹤0.01% 520

Other funds holding MDT

SignatureFD's MDT Position: Q1 2026 in Review

SignatureFD reduced its Medtronic (MDT) stake by 0.35% in Q1 2026, selling an estimated $5.56K and leaving 16,403 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #315.

SignatureFD first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.75M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • SignatureFD held 16,403 shares of Medtronic worth $1.42M as of Q1 2026.
  • SignatureFD sold 58 Medtronic shares in Q1 2026, an estimated $5.56K.
  • Medtronic made up 0.02% of SignatureFD's portfolio in Q1 2026, its #315 holding.
  • SignatureFD first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • SignatureFD's Medtronic position peaked at $1.75M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.